BIR Annual Radiotherapy and Oncology Meeting 2022

31st March - 1st April 2022   (GMT+01:00) Europe/London

Registrations now open!

Thursday 31 March – Friday 1 April 2022
Venue: etc.venues St Paul's, London
CPD: 14 CPD credits (7 credits per day)

This is the second meeting for the BIR, which brings together speakers from around the world and national experts too, to share experiences and expertise in a wide range of aspects for today’s cutting-edge radiotherapy and oncology.  Planned as a blended, hybrid meeting (enabling both face-to-face and virtual attendance and presentation), the latest techniques, technologies, methods and hot-topics will be discussed in this comprehensive meeting taking place over two days.  Renewed opportunities aplenty for networking with fellow professionals and discussing the latest offerings from manufacturers.  

View event programme

Parallel streams will be used to maximise the sessional opportunities, together with expert plenary talks focusing this year on 
•    Immuno-radiotherapy
•    Debate – X-rays or MR for on-treatment adaptive radiotherapy
•    Panel Discussion – Role development and extension in modern radiotherapy and oncology

Keynote talks will headline the main sessions, and topic areas will include:
•    Adaptive Radiotherapy
•    MR Informed Radiotherapy
•    SRS/SABR/Oligomets treatments
•    Engineering/IT/infrastructure
•    Manufacturers presentations
•    Patient voices
•    Advances in Radiotherapy Treatment Planning
•    Particle and other innovative treatments
•    Regulation and Legislation
•    Practice Changing Clinical Trials
•    In practice discussions – Geometric Uncertainties, Radiobiology, On Target Two
•    Optimising Resources - re-use/re-cycle/sustainability
•    Worldwide Challenges in Radiotherapy

Expert teaching sessions will be held at the end of day one, and the start of day two, to provide targeted educational opportunities in areas such as Adaptive Radiotherapy, Challenging Radiotherapy Planning Cases and Brachytherapy.  

Proffered material is once more welcomed in the form of oral presentations, ePosters and short video clips.  All-in-all, the best in radiotherapy and oncology will be featured at this exciting meeting!

Who should attend?  
You!  If you’re working in radiotherapy and oncology, then this meeting is designed for you – and that is for all disciplines.  The BIR is rapidly becoming the home of ALL professionals involved with Radiotherapy and Oncology and is open to all.  So, clinical oncologists, radiographers, physicists, service managers, Linac and IT engineers, dosimetrists, manufacturers, department heads…all are welcome, and there should be something for everyone.

Five Reasons to attend:
•    Enhance your knowledge in the cutting-edge fields of clinical practice
•    Refresh your understanding in key areas 
•    Hear expert opinion and offer your own
•    Network with colleagues and peers, manufacturers and industry reps
•    Share your own research and development work

Call for abstracts
We are now inviting professionals and researchers to submit abstracts (up to 400 words) for 
•    ePosters
•    Short (10 mins max) video presentations
relating to any of the key topic areas noted above, but in particular the issues which challenge our practice – from clinical challenges to sustainability and optimising resources.  Material from all disciplines working in radiotherapy and oncology is welcomed and encouraged – all disciplines play a part in the treatment of our patients, all have a voice to be heard in our practice and its development.  Within the meeting there will be digital screens available for poster viewing in the conference venue and ePoster/video clips will be uploaded onto the BIR website for access by meeting delegates throughout the meeting.  

Submission deadline: 5pm Sunday 9 January 2022

Submit your abstract here

Exhibit at BIR Annual Radiotherapy and Oncology Meeting 2022 

The 'BIR Annual Radiotherapy and Oncology meeting 2022' event offers sponsors an excellent opportunity to reach out to a large number of multidisciplinary medical professionals in a relaxed virtual environment along with an opportunity to choose a speaker of your choice to speak at the event. Please view our exhibiting and sponsorship brochure for the full list of opportunities!

To express your interest, please contact us at 

Registration fees:
BIR Plan 1 member   £280
BIR Plan 2 / Trainee member   £205
BIR Retired / Student member   £95
Non-member   £435

BIR Plan 1 member   £170
BIR Plan 2 / Trainee member   £110
BIR Retired / Student member   £50
Non-member   £280

*Early bird rates expire on Sunday  6 February 2022

BIR Plan 1 member   £295
BIR Plan 2 / Trainee member   £220
BIR Retired / Student member   £110
Non-member   £450

BIR Plan 1 member   £185
BIR Plan 2 / Trainee member   £125
BIR Retired / Student member   £65
Non-member   £295

Photography disclaimer 
The British Institute of Radiology may take photos at events. These images will be used by the BIR to share news about the event and to publicise upcoming events. Images may be used in press releases, printed publicity and published on the website and social media. They will be stored securely, and will be deleted after they are no longer needed for publicity purposes.

Please note, by registering for a BIR event you are giving consent for your photo to be used by the BIR for marketing and publicity purposes. If you would prefer not to be photographed, please email the BIR events team or speak to a member of staff on the day.




Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999


For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit or follow @Elekta on Twitter, Facebook and LinkedIn. A pioneer in precision radiation medicine, Elekta develops and supports a range of advanced linear accelerators (linacs) that enable physicians to deliver precise, rapid and patient-specific radiotherapy for individuals with cancer. Elekta’s line of high definition digital accelerators includes the latest generation Versa HD™ – a system designed to treat a spectrum of tumors throughout the body using both conventional and highly sophisticated techniques – as well as the clinically-proven and widely used Elekta Synergy® and Elekta Infinity™ linacs. Elekta Unity is a state-of-the art MR-Linac that is defining a new standard for personalized radiation therapy based on real-time high resolution anatomical and biological MRI at the point-of-care. Unity combines a Philips high-field 1.5T MRI scanner with a best-in-class 7MV linear accelerator and breakthrough online dose replanning software that are fully integrated to enable adaptive radiotherapy and real-time target monitoring. MOSAIQ® Plaza is a comprehensive suite of digital tools that works seamlessly with Elekta radiotherapy systems to provide the foundation for intelligence-driven, value-based healthcare. MOSAIQ Plaza’s smart data center connects healthcare professionals to patients through every step of their journey to ensure efficient, standardized daily practice. Bringing people and information together, MOSAIQ Plaza allows departments to continuously improve their processes, reduce costs and touch more patients’ lives.

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Siemens Healthineers

Siemens Healthineers is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. For more information and latest product line visit